Table 1.
Site of damage |
Investigated parameters |
Control | Group 1 | Group 2 | Group 3 | Group 4 | Group 5 | Group 6 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1st m | 6th m | p | 1st m | 6th m | p | 1st m | 6th m | p | 1st m | 6th m | p | 1st m | 6th m | p | 1st m | 6th m | p | 1st m | 6th m | p | ||
Edema | 3.67 | 5.5 | ns | 6 | 7.17 | ns | 5.67 | 7.67 | 0.05 | 5 | 5.5 | ns | 4.33 | 7 | 0.02 | 4.33 | 4.83 | ns | 5.67 | 3 | 0.02 | |
Acinar epithelial cell damage | Vacuolization | 4.33 | 3.5 | ns | 6.67 | 6.33 | ns | 5 | 7 | 0.04 | 4.67 | 4.17 | ns | 4 | 5.33 | ns | 5 | 3.67 | ns | 5.33 | 2 | 0.02 |
Peri acinar inflammation | 0 | 0 | ns | 0.67 | 0.17 | ns | 1.33 | 0.17 | ns | 0.67 | 0.17 | ns | 0 | 0.17 | ns | 0 | 0.17 | ns | 2 | 0 | 0.02 | |
Necrosis | 0.67 | 2.33 | ns | 0 | 1.33 | 0.04 | 2 | 0.5 | ns | 1.67 | 1 | ns | 0 | 1 | ns | 0.33 | 0 | ns | 0.67 | 0.17 | ns | |
Ductal system damage | Ectasia | 3 | 3.33 | ns | 6.33 | 5.83 | ns | 4.33 | 6 | ns | 3.67 | 2.5 | ns | 2.67 | 4.67 | 0.01 | 3.67 | 3.5 | ns | 3.33 | 0.83 | 0.04 |
Periductal fibrosis | 0 | 0 | ns | 1 | 3.33 | 0.02 | 2.33 | 3.33 | ns | 1 | 0.33 | ns | 0 | 2.33 | 0.02 | 0 | 1.33 | 0.01 | 0 | 0.67 | ns | |
Interstitial space damage | Periduktal sclerosis | 0 | 0.17 | ns | 0 | 2.17 | 0.02 | 1.33 | 1.83 | ns | 1 | 0 | 0.03 | 0 | 0.33 | ns | 0 | 0.67 | ns | 0 | 0 | ns |
Periductal mucus leakage | 1 | 0.5 | ns | 1 | 1 | ns | 0.67 | 1.33 | ns | 1.33 | 1 | ns | 0.33 | 0.83 | ns | 0.33 | 0.33 | ns | 3 | 0.5 | 0.02 | |
Vascular system damage | Sclerosis | 0 | 0.17 | ns | 1 | 4.5 | 0.01 | 1.67 | 3.5 | ns | 1.33 | 0.5 | ns | 0.67 | 1.17 | ns | 0 | 1.17 | 0.01 | 1.67 | 0.5 | ns |
Total | 12.67 | 15.5 | ns | 22.67 | 31.83 | 0.02 | 24.33 | 31.33 | ns | 20.34 | 15.17 | 0.05 | 12 | 22.83 | 0.02 | 13.66 | 15.67 | ns | 21.67 | 7.67 | 0.02 |
Control = healthy subjects; Group 1= radioiodine; Group 2 = adipose tissue-derived mesenchymal stem cells; Group 3 = amifostine; Group 4 = radioiodine plus amifostine; Group 5 = radioiodine plus adipose tissue-derived mesenchymal stem cells concomitant; Group 6 = radioiodine plus adipose tissue-derived mesenchymal stem cells after 48 h; ns = not significant.